Unc18 Antibodies

Santa Cruz Biotechnology offers a broad range of Unc18 monoclonal antibodies for advanced research in neuroscience and cellular signaling. Unc18 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Unc18, also known as Munc18, plays a critical role in synaptic transmission by regulating the docking and fusion of synaptic vesicles with the presynaptic membrane. Unc18 is essential for neurotransmitter release, making it a key player in neuronal communication and overall brain function. Understanding the mechanisms involving Unc18 is crucial for elucidating various neurological disorders and developing potential therapeutic strategies. Researchers worldwide rely on Unc18 monoclonal antibodies to investigate synaptic vesicle regulation and neurotransmitter release mechanisms. Advanced research techniques using Unc18 monoclonal antibodies have revealed important insights into neurological conditions and potential treatment approaches. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to neuroscience research and advance our understanding of neurological disorders.